Summary

Analysis of Granulocyte-Macrophage Colony-Stimulating Factor-Producing T Helper Cells in a Mouse Model of Contact Hypersensitivity

Published: March 10, 2022
doi:

Summary

Here, we present a simple and standardized method of analyzing the granulocyte-macrophage colony-stimulating factor-producing T helper subset in vivo.

Abstract

Parallel to traditional Th1/Th2/Th17/Treg lineages, granulocyte-macrophage colony-stimulating factor-producing T helper (Th-GM) cells have been identified as a distinct subset of T helper cells (GM-CSF+ IFN-γ IL-17A IL-22 effector CD4+ T cells) in human and mice. Contact hypersensitivity (CHS) is considered an excellent animal model for allergic contact dermatitis (ACD) in human, manifesting an intact T cell-mediated immune response. To provide a standardized and comprehensive assay to analyze the Th-GM cell subset in the T cell-dependent immune response in vivo, a murine CHS model was induced by sensitization/challenge with a reactive, low-molecular-weight, organic hapten, 2,4-dinitrofluorobenzene (DNFB). The Th-GM subset in effector CD4+ T cells generated upon immunization with the hapten was analyzed by flow cytometry. We found that Th-GM was mainly expanded in lesions and draining lymph nodes in the DNFB-induced CHS mouse model. This method can be applied to further study the biology of Th-GM cells and pharmacological research of therapeutic strategies centered on GM-CSF in various conditions, such as ACD.

Introduction

The granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing T helper cells-the Th-GM subset-has been emerging as a distinct subset of T helper cells in human and mice and is considered to comprise "GM-CSF-expressing only" (GM-CSF+ IFN-γ IL-17A IL-22) CD4 T cells identified by single-cell RNA analysis, mass cytometry, and GM-CSF fate mapper mice1,2,3. In 2014, Sheng et al. reported signal transducer and activator of transcription 5 (STAT5) programming of the Th-GM subset and conceptualized the "Th-GM" subset for the first time4,5. Th-GM cells are characterized by cytokine expression of GM-CSF, IL-2, TNF-α, IL-3, CCL20, and chemokine receptors C-X-C chemokine receptor type (CXCR) 4 or CXCR61,2. STAT and/or the NF-κB pathway are essential for Th-GM lineage differentiation. An in vitro method was established to differentiate naïve CD4 T cells into Th-GM cells using IL-7 in the presence of TCR stimuli6. Meanwhile, the cytokines IL-23 and IL-1β were shown to maintain the expression and pathogenicity of Th-GM cells ex vivo3,7.

Elevation of Th-GM cells has been associated with several autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis2,8,9, suggesting a potential role in the pathogenesis of autoimmunity10. Accumulating evidence suggests that GM-CSF can function as an inflammatory mediator. Mice genetically overexpressing Csf2 (gene encoding GM-CSF) in CD4+ T cells spontaneously developed neurological deficits accompanied by the infiltration of phagocytes into the central nervous system. In a T cell-transfer colitis model, the adoptive transfer of Csf2−/− T cells into Rag1−/− mice significantly reduced the clinical and histopathological features of the disease. However, there are few reports of the roles of the Th-GM subset in allergic diseases, such as ACD.

ACD is among the most common inflammatory dermatological conditions with high prevalence in work and life environments11,12. It is a type IV delayed-type hypersensitivity response mediated by an intact immune circuit that develops in two temporally segmented phases: sensitization and elicitation. Human ACD is triggered by exposure to some chemicals (haptens or metals) that lead to sensitization. During this phase, a T cell-mediated response is primed by hapten-protein complexes presented by antigen-presenting cells. Upon subsequent exposure to the same hapten, hapten-specific effector and memory T cells are reactivated and localize to the skin, a process involving the infiltration of a variety of immune cell populations. This acute inflammatory response is known as elicitation, resulting in the full development of lesions13. Human ACD can be studied using animal models of contact hypersensitivity (CHS)14.

The CHS model induced by a reactive, low-molecular-weight, organic hapten, 2,4-dinitrofluorobenzene (DNFB), is a commonly used murine model that has been utilized in the study of the pathology as well as potential therapeutic interventions of ACD15,16. Thus, this T cell-dependent model could be applied to study the generation of the Th-GM subset in allergic disease. Here, we induced a murine model of CHS with DNFB, analyzed the generation of Th-GM in lesions and draining lymph nodes, and found that the Th-GM subset was mainly expanded upon reexposure to the same hapten. This suggests that the Th-GM subset could be essential for ACD development and represents a specific therapeutic target in ACD.

Protocol

All mice utilized in this protocol were on the C57BL/6 genetic background, kept under specific pathogen-free conditions, and provided with food and water ad libitum. All experiments were approved by the animal welfare ethical review body of West China Medical Center, Sichuan University (20210302059). 1. Reagent and material preparation 0.5% DNFB solution as a sensitizer For sensitization of 10 mice, prepare 1.1 mL of acetone/olive oil 4:1 (v/v)…

Representative Results

DNFB-induced CHS (contact hypersensitivity) in mice To induce CHS in mice, the mice were sensitized and challenged with DNFB applied to the ear skin, as illustrated in Figure 1A. Ear thickness, an indicator of epidermal spongiosis, was markedly increased in DNFB-challenged mice compared to vehicle-treated mice (Figure 1B, 70 vs 3 µm at day 1, 203 vs 7.5 µm at day 2, 276 vs 5 µm at day 3). Seventy-two hours after the challeng…

Discussion

This protocol provides a simple in vivo assay to analyze the generation and expansion of the Th-GM cell subset. It is essential to utilize a T cell-mediated disease model in mice initiated by haptens or antigens, mimicking that activation in human. DNFB is a small-molecule hapten that is more economical and time-saving than peptide or protein antigens for triggering the T cell immune response in vivo18,19. During the course of the disease, we ob…

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (No. 81602763, 81803142, 82003347), the Excellent Researcher Program of China Postdoctoral Science Foundation (No. 2017T100700), and the Regular Researcher Program of China Postdoctoral Science Foundation (No. 2016M592673). The authors would like to thank Yan Wang and Meng-Li Zhu (Core Facilities of West China Hospital, Sichuan University) for technical support of flow cytometry in this study.

Materials

2,4-dinitrofluorobenzene BT REAGENT P0001746 CAS NO: 70-34-8
Acetone CHRON CHEMICALS / 67-64-1
anti-CD4 antibody Biolegend 300506 1:100 Diluted
anti-CD44 antibody Biolegend 103012 1:100 Diluted
anti-CD62L antibody Biolegend 104417 1:100 Diluted
anti-GM-CSF antibody BD Bioscience 554507 1:100 Diluted
anti-IFN-γ antibody Biolegend 505836 1:100 Diluted
anti-IL-17A antibody BD Bioscience 563354 1:100 Diluted
anti-IL-22 antibody Biolegend 516411 5 µL/test
CD45 Biolegend 103101 1:200 Diluted
Chloral hydrate CHRON CHEMICALS / 302-17-0
Dial thickness gauge (0.01 mm type) PEACOCK G-1A /
DMSO LIFESCIENCES D8371 67-68-5
EDTA Na2 Solarbio E8030 6381-92-6
F4/80 Biolegend 123102 1:200 Diluted
Fixable Viability Stain 780 BD Bioscience 565388 1:1,000 Diluted, viability dye
Flow cytometer BD Bioscience BD FACS ARIA II SORP /
GraphPad Prism GraphPad Software Prism 7 Software for statistics and graphing
Intracelluar Fixtation and Permeablization Buffer Set Thermo Fisher 88-8824-00 prepared freshly
Ionomycin Sigma-Aldrich 407951 CAS NO: 56092-81-0
Ly6G Biolegend 127602 1:200 Dilutied
NovoExpress Agilent / Software for flow cytometry data analysis; https://www.agilent.com.cn/zh-cn/product/research-flow-cytometry/flow-cytometry-software/novocyte-novoexpress-software-1320805
Olive oil YUANYE BIO S30503 8001-25-0
PMA Sigma-Aldrich P8139 CAS NO: 16561-29-8
Protein Transport Inhibitor (Containing Brefeldin A) BD Bioscience 555029 1 µL/mL

Riferimenti

  1. Rasouli, J., et al. A distinct GM-CSF(+) T helper cell subset requires T-bet to adopt a TH1 phenotype and promote neuroinflammation. Science Immunology. 5 (52), (2020).
  2. Galli, E., et al. GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis. Nature Medicine. 25 (8), 1290-1300 (2019).
  3. Komuczki, J., et al. Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1beta. Immunity. 50 (5), 1289-1304 (2019).
  4. Sheng, W., et al. STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation. Cell Research. 24 (12), 1387-1402 (2014).
  5. Herndler-Brandstetter, D., Flavell, R. A. Producing GM-CSF: a unique T helper subset. Cell Research. 24 (12), 1379-1380 (2014).
  6. Lu, Y., Fu, X. Y., Zhang, Y. In vitro differentiation of mouse granulocyte-macrophage-colony-stimulating Factor (GM-CSF)-producing T Helper (THGM) Cells. Journal of Visualized Experiments: JoVE. (139), e58087 (2018).
  7. Hu, Y., et al. Interleukin-1beta-induced IRAK1 ubiquitination is required for TH-GM-CSF cell differentiation in T cell-mediated inflammation. Journal of Autoimmunity. 102, 50-64 (2019).
  8. Reynolds, G., et al. Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. Annals of the Rheumatic Diseases. 75 (5), 899-907 (2016).
  9. Al-Mossawi, M. H., et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nature Communation. 8 (1), 1510 (2017).
  10. Wicks, I. P., Roberts, A. W. Targeting GM-CSF in inflammatory diseases. Nature Reviews Rheumatology. 12 (1), 37-48 (2016).
  11. Scheinman, P. L., et al. Contact dermatitis. Nature Reviews Disease Primers. 7 (1), 38 (2021).
  12. Pesonen, M., Koskela, K., Aalto-Korte, K. Contact urticaria and protein contact dermatitis in the Finnish Register of Occupational Diseases in a period of 12 years. Contact Dermatitis. 83 (1), 1-7 (2020).
  13. Vocanson, M., Hennino, A., Rozieres, A., Poyet, G., Nicolas, J. F. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy. 64 (12), 1699-1714 (2009).
  14. Gaspari, A. A., Katz, S. I., Martin, S. F. Contact hypersensitivity. Current Protocols in Immunology. 113, 1-7 (2016).
  15. Manresa, M. C. Animal models of contact dermatitis: 2,4-dinitrofluorobenzene-induced contact hypersensitivity. Methods in Molecular Biology. 2223, 87-100 (2021).
  16. Kim, J. H., et al. CD1a on Langerhans cells controls inflammatory skin disease. Nature Immunology. 17 (10), 1159-1166 (2016).
  17. Canene-Adams, K. Preparation of formalin-fixed paraffin-embedded tissue for immunohistochemistry. Methods in Enzymology. 533, 225-233 (2013).
  18. Achuthan, A., et al. Cytokine-induced acute inflammatory monoarticular arthritis. Methods in Molecular Biology. 1784, 215-223 (2018).
  19. Stromnes, I. M., Goverman, J. M. Active induction of experimental allergic encephalomyelitis. Nature Protocols. 1 (4), 1810-1819 (2006).
  20. Kruisbeek, A. M., Shevach, E., Thornton, A. M. Proliferative assays for T cell function. Current Protocols in Immunology. , (2004).
  21. Cossarizza, A., et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). European Journal of Immunology. 49 (10), 1457 (2019).
This article has been published
Video Coming Soon
Keep me updated:

.

Citazione di questo articolo
Teng, X., Li, L., Tang, M., Li, H., Ren, X., Jiao, L., Wu, S., Mou, D., Miao, Z. Analysis of Granulocyte-Macrophage Colony-Stimulating Factor-Producing T Helper Cells in a Mouse Model of Contact Hypersensitivity. J. Vis. Exp. (181), e63755, doi:10.3791/63755 (2022).

View Video